Login  
Research Report
 
 
Home >> Country >> India >> Company
Company Name : Emami
Y/E Mar, Rs mn FY11 FY12 FY13 FY14E FY15E
Price739
Target740
RecoNEU
Net Sales12,47114,53516,99118,20822,031
Growth (%)1717721
EBIDTA2,5342,9683,4704,4135,205
EBITDA Margin20202424
Net Profit2,2862,5863,1444,0954,509
Growth (%)13223010
EPS, Rs1517141820
PER, x48.943.253.340.937.2
EV/EBIDTA, x6656483731
P/BV, x1616221713
ROE, % 3933374042
Total debt/Equity (%)2.7-16.3-20.9-26.9-33.2
Latest Reports
Date Description Country Analyst Download
25-May-2023 Emami (HMN IN) 4QFY23 Result Update: Problems of the past come to fore ; Downgrade to NEUTRAL with Revised TP of Rs. 430/ India Vishal Gutka
03-Feb-2023 Emami (HMN IN) 3QFY23- Result Update - Delayed winter, adverse mix weighs on profitability ; Maintain BUY with Revised TP of Rs. 485/ India Vishal Gutka
11-Nov-2022 Emami (HMN IN) 2QFY23: Quarterly Update: Weak operating performance; Maintain BUY with Revised TP of Rs. 550/ India Vishal Gutka
29-Jul-2022 Emami (HMN IN) 1QFY23 Result Update: Favorable risk reward ; Maintain BUY with TP of Rs. 535 India Vishal Gutka
13-May-2022 Emami (HMN IN) 4QFY22: Result Update - Favorable risk reward ; Maintain BUY with Revised TP of Rs. 525 India Vishal Gutka
30-Mar-2022 Emami (HMN IN): Company Update - Fortifying its presence in talcum powder segment ; Maintain BUY with TP of Rs. 550 India Vishal Gutka
21-Feb-2022 Emami (HMN IN): Company Update - Favorable risk reward ; Maintain BUY with TP of Rs. 600 India Vishal Gutka
29-Oct-2021 Emami (HMN IN)- 2QFY22: Result update - Broad based performance despite covid tailwinds receding; Maintain BUY with TP of Rs. 700 India Vishal Gutka
22-Jul-2021 Emami Ltd: Company Update - Decoding Healthcare 2.0 : Maintain BUY India Vishal Gutka
18-Jun-2021 Emami Ltd - Company Update: Bright spot amid dark clouds - Maintain BUY India Vishal Gutka
25-May-2021 Emami Ltd 4QFY21: Focus on healthcare and distribution expansion to drive growth in FY22 - Maintain BUY India Vishal Gutka
11-Dec-2020 Emami Ltd: Company Update: Near-term outperformance to outweigh structural concerns - Upgrade to BUY India Vishal Gutka
06-Nov-2020 Emami Ltd 2QFY21: Narrative turns favourable; now sustainability matters - Maintain Neutral India Vishal Gutka
07-Aug-2020 Emami Ltd Q1FY21: NPD’s and Zandu drives outperformance - Maintain Neutral India Vishal Gutka
07-Feb-2020 Emami Ltd Q3FY20: Focus shall shift to core as overhang goes away - Maintain Neutral India Vishal Gutka
08-Aug-2019 Emami Q1FY20: When this seasonality jinx will end? India Vishal Gutka
29-May-2019 Emami Q4FY19: Who moved my growth? India Vikash Singh
01-Feb-2019 Emami Q3FY19: Seasonality jinx continues India Vishal Gutka
30-Oct-2018 Emami Q2FY19:Wait for revival becomes elongated India Vishal Gutka
02-Aug-2018 Emami Q1FY19:Awaiting revival; valuation remains saving grace India Vishal Gutka
03-May-2018 Emami Q4FY18: Not out of woods yet India Vishal Gutka
30-Jan-2018 Emami Q3FY18: Awaiting revival India Vishal Gutka
09-May-2017 Emami Q4FY17: International business impacts growth; Maintain Neutral India Jubil Jain
30-Jan-2017 Emami Q3FY17: Winter portfolio drives growth; Maintain Neutral India Jubil Jain
27-Oct-2016 Emami Q2FY17: Kesh King sales recover; Maintain Neutral India Jubil Jain
1 2 
Copyright © 2013. Brought to you by PhillipCapital (India) Pvt. Ltd.      Designed and developed by C-MOTS Infotech (ISO 9001:2015 certified)